Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Wednesday, May 6, 2026

Snapshot: May 6, 2026 · 6:00 PM 100 stocks analyzed

Strong Up Day

Wed, May 6, 2026 Broad Rally Extreme

Extreme dispersion defined the day as S&P surged 1.5% on a broad rally, but wild single-stock swings—with top gainers averaging +35% and top losers averaging -28%—overwhelmed th…

60% Extreme dispersion dominated: 50 stocks jumped an average +35% (led by STFS at +97%, EVC at +93% on strong earnings) while 50 others plummeted an average -28% (EZGO crashed -92%, GDC collapsed -79%), creating a stock-picker's paradise that dwarfed the headline broad rally.
25% Broad market rally powered by earnings beats and AI infrastructure optimism: S&P 500 +1.48%, NASDAQ +2.02%, Russell 2000 +1.47% all moved in sync, with Financial Services stocks dominating the gainers list (40% share) and names like SMCI (+25% on guidance raise), EVC (+93% on 114% revenue surge), and HUT (+35% on $9.8B AI data center lease) leading the charge.
15% Wave of first-time debutants and news-grounded reversals created turnover: Five stocks returned to the gainers list for the first time (STFS, PMAX, EVC, OSS, SMCX), while earnings misses triggered sharp reversals in mega-cap names like KVYO (-32% despite 28% revenue growth), NICE (-23% on weak guidance), and ANGI (-35% on revenue miss), signaling high conviction repricing across the tape.

Worst avg loser % YTD (-27.7%) Financial Services drove 40% of gainers 5 names returned after long absences STFS — first appearance PMAX — first appearance

Market Regime

Wed, May 6, 2026 Risk-On conf: high macro · prototype

+45

Tailwind −100 … +100 · + tailwind / − headwind

VIX17.4 p52 Drawdown0.0% Held18d · extended SinceApr 13

Top drivers: S&P 20d return ▲ S&P vs 20d avg ▲ S&P vs 50d avg ▲

processId: history-market-regime

Market Indexes

Wed, May 6, 2026 4

S&P 500

7,366.46

+107.24

+1.48%

NASDAQ Composite

25,838.94

+512.82

+2.02%

Russell 2000

2,886.77

+41.77

+1.47%

VIX

17.39

+0.01

+0.06%

Biggest Gainers

Wed, May 6, 2026 50

STFS

Star Fashion Culture Holdings LimitedCommunication Services

$7.92+$3.89

+96.5%

NASDAQ · Mkt cap $5.3 M

No news headlines were found in the last 48 hours for STFS, so the 96.53% gain cannot be attributed to a specific announced event. The jump likely reflects technical trading, short covering, or unindexed company news.

Star Fashion Culture Holdings experienced an exceptional single-day rally to become the top gainer on NASDAQ, yet zero financial news appears in the Yahoo Finance RSS feed for the relevant period. This disconnect suggests the catalyst was either extremely localized (a press release not yet syndicated broadly), technical in nature (short squeeze or algorithmic momentum), or based on information circulating outside major news channels. For a micro-cap fashion and apparel stock, common catalysts during low-news environments include insider buying announcements, unexpected contract wins, insider social media mentions, or simply extreme illiquidity creating outsized price swings from modest volume. Without access to the company's own press releases or SEC filings filed in the last 48 hours, a definitive cause cannot be established from the evidence provided.

PMAX

Powell Max Limited Class A Ordinary SharesFinancial Services

$4.14+$2.02

+95.3%

NASDAQ · Mkt cap $2.1 M

No news headlines were found in the last 48 hours, so the 95% gain cannot be directly attributed to a reported event. The move likely reflects a technical catalyst such as short covering, options expiry, or delayed news absorption.

PMAX jumped nearly 95 percent on May 6, 2026, but Yahoo Finance returned zero headlines in the preceding 48 hours. This disconnect suggests the catalyst was either not yet captured in headlines at snapshot time, occurred earlier and is being repriced, or is technical in nature. Penny stocks and small-cap NASDAQ listings commonly experience volatile moves on short squeezes, options-driven gamma events, or broad sector rotations that precede formal news coverage. Without access to SEC filings, insider transactions, earnings dates, or regulatory developments announced in the last week, we cannot identify a specific corporate event. The absence of news combined with the magnitude of the move points toward either (1) a technical event like short covering pressure or options expiry gamma, or (2) a news announcement that had not yet propagated to Yahoo Finance RSS at the time of the snapshot.

EVC

Entravision Communications CorporationCommunication Services

$7.69+$3.71

+93.2%

NYSE · Mkt cap $776 M

Entravision reported Q1 2026 revenue surging 114% year-over-year to $197 million, driven by strong growth in its Advertising Technology and Services segment, triggering the 93% gain.

The earnings headlines establish that Entravision delivered a substantial consolidated revenue beat in Q1 2026, with total revenue nearly doubling versus the prior year quarter. The growth was explicitly attributed to rapid expansion in the ATS segment, while the Media segment posted more modest 4% revenue growth. This represents a significant acceleration in top-line performance and signals that the company's pivot toward advertising technology is gaining traction and scale. For a stock trading at $7.69, a 93% single-day move following a 114% revenue growth announcement is consistent with market re-rating of growth prospects, though the headline summaries lack specific details on profitability, margins, guidance, or forward outlook that might explain the magnitude of the move more precisely.

OSS

One Stop Systems, Inc.Technology

$15.33+$5.56

+56.9%

NASDAQ · Mkt cap $333 M

One Stop Systems beat Q1 earnings and revenue estimates by significant margins while reporting 55% year-over-year revenue growth and improved margins, driving the 56.91% stock surge as a beneficiary of enterprise AI and edge computing demand.

The earnings release and call transcript published on May 6 document a strong Q1 2026 performance: revenue grew 55% year-over-year to $8.1 million, gross margin expanded 610 basis points to 51.6%, and the company beat earnings estimates by 120% and revenue estimates by 15.28%. Management cited validation of OSS's position in AI autonomy and edge computing applications. The magnitude of the earnings beat combined with top-line growth acceleration and margin expansion appears to have triggered substantial institutional and retail buying, particularly given the stock's small market cap where large moves are more common. The timing aligns precisely with publication of earnings materials on May 6, suggesting market repricing of the growth narrative and profitability inflection.

ERNA

Ernexa Therapeutics Inc.Healthcare

$6.04+$2.05

+51.4%

NASDAQ · Mkt cap $5.2 M

Ernexa Therapeutics announced preclinical data showing its ERNA-101 cell therapy achieved 100% survival and complete tumor clearance in ovarian cancer models, triggering a 51% stock surge as investors responded to the positive immunotherapy results.

Two nearly identical news releases published on 2026-05-06 reported landmark preclinical findings for ERNA-101 in combination with PD-1 blockade, demonstrating complete tumor elimination and long-term survival in ovarian cancer models. The headlines explicitly frame this as a "breakthrough" and "game-changing" result positioned to drive future clinical advancement and shareholder value. For early-stage therapeutics companies, preclinical data showing efficacy at this level—particularly complete response rates and survival—typically generates strong market enthusiasm because it supports the investment thesis and de-risks the path to clinical trials. The 51% gain ranks ERNA as the fifth-largest gainer of the day, consistent with the magnitude of positive catalyst this kind of data represents for a biotech stock. No countervailing news or clinical setbacks appear in the provided headlines.

SMCX

Daily Target 2X Long SMCI ETFFinancial Services

$17.62+$5.77

+48.7%

WFCF

Where Food Comes From, Inc.Industrials

$18.13+$5.76

+46.6%

NASDAQ · Mkt cap $62 M

No headlines were published in the last 48 hours to explain WFCF's 46.56% surge, so the catalyst remains unknown; the move may reflect delayed news dissemination, technical positioning, or an untracked announcement.

Yahoo Finance returned zero headlines for WFCF in the 48 hours preceding this +46% jump, which is unusual for a stock ranking in the top 7 gainers. This gap could indicate several things: the catalyst may be very recent and not yet indexed by the news feed, the move could be driven by after-hours trading or pre-market activity that gets backfilled later, or the announcement occurred via a channel not yet reflected in this RSS pull. For a company like Where Food Comes From, which operates in supply-chain verification and food traceability, typical catalysts would include contract wins, expansion announcements, sustainability initiatives, or operational partnerships. Without evidence in hand, attributing the move to any specific event would be speculative. The magnitude of the jump (46%) is substantial enough to suggest a discrete event rather than drift, but confirmation requires either delayed news or company filings.

AHMA

Ambitions Enterprise Management Co. L.L.CConsumer Cyclical

$1.60+$0.50

+45.5%

NASDAQ · Mkt cap $46 M

No news headlines were found in the last 48 hours, so the 45% gain cannot be attributed to any disclosed company announcement. The move likely reflects technical trading, retail interest, or off-exchange information not yet widely reported.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst for AHMA's sharp 45% rise to $1.60. Stocks at this price level and market cap tier are often subject to technical bounces, short squeezes, or momentum-driven trading by retail investors, especially after periods of decline. Without access to intraday social media discussion, options activity, short interest data, or delayed press releases, we cannot determine whether this was a coordinated retail push, a short covering event, or simply a mean reversion bounce. It is also possible that relevant news exists but has not yet appeared in the Yahoo Finance RSS feed checked at snapshot time. The lack of a corresponding headline is itself notable and limits confidence in any specific explanation.

BLMN

Bloomin' Brands, Inc.Consumer Cyclical

$8.12+$2.36

+41.0%

NASDAQ · Mkt cap $831 M

Bloomin' Brands beat Q1 earnings and revenue expectations and provided upbeat forward guidance, particularly citing progress on its Outback Steakhouse turnaround, driving the 41% single-day jump.

The headlines establish a clear earnings catalyst on May 6, 2026. Bloomin' Brands reported Q1 2026 results that exceeded Wall Street estimates on both earnings (17.59% surprise) and revenue (1.77% surprise), with non-GAAP EPS of $0.67 per share. Critically, executives highlighted early progress in Outback Steakhouse turnaround efforts during the earnings call and issued stronger-than-expected guidance for the current quarter. The consensus across multiple sources is that the combination of the earnings beat plus improved forward outlook, particularly around the Outback brand momentum, drove the sharp rally. While revenue remained flat year-over-year at $1.06 billion, the profitability metrics and management commentary on operational improvements appear to have resonated strongly with investors seeking a turnaround story in casual dining.

FLEX

Flex Ltd.Technology

$134.73+$38.28

+39.7%

NASDAQ · Mkt cap $40 B

Flex reported better-than-expected Q4 earnings with 17% revenue growth and announced a planned spinoff of its high-margin Cloud and Power Infrastructure segment into a new publicly traded company, triggering the massive gain.

Flex delivered a double catalyst on May 5-6: strong fiscal Q4 results beating both earnings and revenue estimates, with sales jumping 17% year-over-year to $7.5 billion and adjusted EPS of $0.93 exceeding expectations. More significantly, the company announced Board approval for a spinoff of its Cloud and Power Infrastructure (CPI) segment into an independent publicly traded entity. The news highlighted record quarterly margins in the CPI business, which is typically a high-growth, high-margin operation. Spinoff announcements often drive substantial stock appreciation because they unlock hidden value by separating higher-growth or higher-margin divisions from slower or lower-margin operations, allowing each to be valued independently and potentially access capital markets more efficiently. The combination of operational beat plus transformative corporate action explains the 39.69% single-day surge.

AMDG

Leverage Shares 2x Long AMD Daily ETF

$82.14+$22.19

+37.0%

NASDAQ

No news headlines appeared in the last 48 hours, but AMDG is a 2x leveraged long ETF on AMD, so a strong rally in AMD stock on May 6 would naturally amplify into a ~37% gain through the leverage mechanism.

Yahoo Finance shows zero news headlines for AMDG in the past 48 hours, so no specific corporate event or market catalyst can be identified from the provided sources. However, AMDG's structure explains the magnitude of the move without requiring a headline-level event. As a 2x daily leverage ETF tracking AMD, a +18% to +20% move in the underlying AMD stock on a single day would produce roughly a +36% to +40% move in AMDG. The most likely cause is therefore a significant rally in AMD itself on May 6. The causes of that AMD rally remain unknown from this data set but could include broad semiconductor sector strength, positive guidance updates reported elsewhere, successful product announcements, or other market sentiment shifts affecting the chip sector. The leverage mechanism here is structural amplification rather than a new catalyst specific to the ETF itself.

AMDL

GraniteShares 2x Long AMD Daily ETF

$48.41+$13.07

+37.0%

NASDAQ

No news headlines were found in the last 48 hours, but AMDL is a 2x leveraged ETF tracking AMD, so the 36.97% gain likely reflects a sharp rally in AMD stock itself, amplified by the fund's daily reset mechanism.

The absence of any news in the Yahoo Finance RSS feed for the past 48 hours means there is no identified catalyst headline to point to. However, this is not a mystery because AMDL is specifically designed as a 2x long daily leveraged fund on AMD. If AMD stock rallied approximately 18-19% on May 6, 2026, the 2x daily leverage would produce a move close to the 36.97% observed. The true driver would be AMD's underlying price action, which could stem from semiconductor sector strength, a company announcement not yet indexed in the news feed provided, positive earnings or guidance, short-covering, or broad market momentum. Without access to AMD's actual price move or relevant news on the underlying, the specific cause remains unknown; we can only confirm that the leveraged structure explains why AMDL moved larger than its underlying would move on a 1x basis.

AMUU

Direxion Daily AMD Bull 2X ETF

$168.90+$45.20

+36.5%

NASDAQ

No news headlines were reported in the last 48 hours, but the 36.54% gain in AMUU is most likely driven by a sharp rally in the underlying AMD stock, which this 2X leveraged ETF amplifies by design.

AMUU is a Direxion Daily AMD Bull 2X leveraged ETF, meaning it is engineered to deliver approximately twice the daily return of AMD stock. With no recent news headlines available, the jump cannot be attributed to company-specific announcements about AMD itself. However, the structure of this security explains the outsized move: if AMD gained roughly 18-20% on May 6th, AMUU would naturally deliver close to the observed 36.54% return as a mechanical function of its 2X leverage. The catalyst for the underlying AMD move could stem from broader semiconductor strength, positive market sentiment, a delayed earnings beat or guidance raise, analyst upgrades, or other technical factors affecting the chip sector. Without access to AMD-specific news or market data from that date, the exact trigger cannot be determined, but the magnitude of the AMUU move is entirely consistent with a significant single-day rally in its underlying asset.

SEGG

Sports Entertainment Gaming Global CorporationConsumer Cyclical

$1.37+$0.36

+35.6%

NASDAQ · Mkt cap $8.4 M

SEGG surged 35.64% following a media report announcing a 1,400% pro forma revenue increase to $10.3 million after acquiring Veloce Media Group, with combined assets now exceeding $125 million.

The headline establishes a major acquisition by SEGG of Veloce Media Group, disclosed on 2026-05-06. The reported metrics are striking: pro forma revenue jumped to over $10.3 million (described as a 1,400% increase, implying prior revenue around $700k), and combined pro forma assets exceed $125 million. For a microcap stock trading at $1.37, a transformative acquisition that dramatically scales both revenue and asset base is a material positive catalyst. The market appears to have responded to the scale-up and the strategic expansion of the platform. However, the headline does not provide details on acquisition price, financing structure, or synergy assumptions, so the market may be pricing in optimistic expectations about integration and future growth that remain unvalidated.

HUT

Hut 8 Corp.Financial Services

$108.94+$28.43

+35.3%

NASDAQ · Mkt cap $11 B

Hut 8 surged 35% after announcing a $9.8 billion, 15-year AI data center lease at its Texas Beacon Point campus, expanding its contracted AI infrastructure capacity to 597 MW despite missing Q1 earnings expectations.

The headline evidence is direct and consistent. On May 6, 2026, Hut 8 announced a major lease agreement for 352 MW of AI data center capacity at its Nueces County, Texas facility, valued at $9.8 billion over 15 years with an undisclosed hyperscale customer. Multiple sources confirm this lease significantly expanded the company's contracted AI infrastructure backlog and long-term revenue visibility, marking a strategic pivot from cryptocurrency mining to AI infrastructure landlord. The company simultaneously reported Q1 2026 earnings that missed consensus estimates ($71 million revenue versus $78.7 million expected), yet investors rewarded the stock because the massive lease deal and expanded power capacity pipeline appear to have outweighed the earnings miss. The repricing reflects investor confidence in the company's transformation narrative and visibility into future high-margin contracted revenue, with comparable gains seen in other former mining stocks like Riot Platforms (+13%).

KEEX

Defiance Daily Target 2X Long BITF ETF

$68.71+$17.52

+34.2%

AMEX

No news headlines appeared in the last 48 hours, but KEEX is a 2X leveraged ETF tracking Bitfarms (BITF), so a strong move in Bitcoin or BITF stock would be amplified roughly double in this fund.

The absence of any news in the provided headlines makes direct causation impossible to establish. However, KEEX is structurally a daily rebalancing leveraged ETF with approximately 2X exposure to Bitfarms Ltd, a Bitcoin mining company. A 34% gain in KEEX would be consistent with an underlying move of roughly 17% in BITF or a similar percentage surge in Bitcoin price itself. Leveraged ETFs amplify daily moves in their underlying assets, so the jump likely reflects strength in either Bitcoin, Bitfarms stock, or both on May 5-6, 2026. Without access to price data for those underlying assets or any news explaining the move, the catalyst remains unknown, though Bitcoin volatility and mining sector sentiment are the most probable categories.

AVTX

Avalo Therapeutics, Inc.Healthcare

$21.81+$5.55

+34.1%

ZTEK

Zentek Ltd.Healthcare

$0.66+$0.17

+34.1%

NASDAQ · Mkt cap $75 M

Zentek announced it is now accepting Canadian commercial orders for its ZenGUARD Enhanced Air Filters following Health Canada regulatory approval, likely driving the 34% gain as it represents a major commercialization milestone for the graphene-enhanced filtration technology.

The headline establishes a concrete regulatory achievement: Health Canada has classified ZenGUARD Enhanced Air Filters in a way that permits commercial orders in Canada. This is a material progression from development to revenue generation for a small-cap biotech/materials company. The filters use patented graphene-enhanced media and have been tested to ASHRAE standards, suggesting the product is legitimate and differentiated. For a stock trading near $0.66, regulatory clearance and order-acceptance status represents the kind of de-risking event that can trigger significant single-day rallies, particularly if investors were waiting for proof of commercialization. The 34% gain ranks it as the 18th biggest gainer of the day, consistent with how small-cap materials or health-tech stocks respond to first major regulatory wins.

BGDE

Big Digital Energy, Inc.Financial Services

$6.29+$1.59

+33.8%

NASDAQ · Mkt cap $41 M

No news headlines were found in the last 48 hours, so the 33.83% jump cannot be tied to a specific announced catalyst; the move likely reflects technical trading, delayed news pickup, or market rumors in a lower-liquidity stock.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it difficult to pinpoint a concrete cause for BGDE's strong rally. Given that the stock is ranked 19th in daily gainers and moved 33.83%, this is a substantial move for what appears to be a small-cap energy company. Possible explanations include a delayed announcement not yet captured in the feed, technical buying after oversold conditions, short-covering in a thinly traded name, or market chatter around energy commodities or digital/blockchain adoption trends in the sector. Without corroborating headlines, any specific narrative remains speculative.

RIOX

Daily Target 2X Long RIOT ETF

$49.02+$12.38

+33.8%

AMEX

No news headlines were published in the last 48 hours, but RIOX is a 2X leveraged long Bitcoin mining ETF that amplifies moves in the underlying RIOT stock; a significant rally in Bitcoin or RIOT likely drove the 33.79% gain.

No relevant news headlines appear in the last 48 hours to directly explain the move. However, RIOX's structure provides a clear mechanistic explanation for the magnitude of the gain. RIOX is a daily target 2X leveraged long ETF tracking RIOT, which is the largest pure-play Bitcoin mining company. A leveraged ETF amplifies both gains and losses of its underlying by a fixed multiple on a daily basis. A roughly 17% move in RIOT would translate to approximately 33-34% in RIOX on a single day. This means the jump likely reflects either a sharp rally in Bitcoin prices, a positive news event affecting RIOT or the broader mining sector, or technical buying pressure in leveraged instruments. Without headlines, the specific catalyst remains unidentified, but the magnitude is consistent with RIOT moving materially higher.

OKLL

Daily Target 2X Long OKLO ETF

$13.45+$3.31

+32.6%

NASDAQ

No relevant news headlines were found in the last 48 hours, but the 32.64% gain in this 2X leveraged long OKLO ETF was likely driven by a sharp rally in the underlying OKLO stock, which the ETF amplifies.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst for today's move. However, OKLL is a daily target 2X leveraged long ETF tracking OKLO (Oklo Inc., a nuclear energy company), which means the fund's price moves roughly double the underlying stock's moves before fees and decay. A 32.64% gain in OKLL implies an approximately 16% or greater move in OKLO itself. For a nuclear or clean energy stock, such a move could stem from regulatory announcements, contract wins, earnings surprises, sector momentum, or technical buying pressure that occurred before the news cycle captured it. The leveraged structure explains why OKLL ranks as a top gainer despite no headlines appearing in the provided 48-hour window; the underlying asset moved substantially, and the 2X multiplier amplified it.

SMX

SMX (Security Matters) Public Limited CompanyIndustrials

$1.53+$0.37

+31.9%

NASDAQ · Mkt cap $17 M

No news was reported in the last 48 hours, so the 31.90% gain cannot be directly attributed to a disclosed catalyst; the move likely reflects technical trading, short covering, or unindexed news flow.

Security Matters (SMX) surged 31.90% to rank among the day's biggest gainers, but no headlines appeared in the 48-hour window preceding the move. This disconnect between a substantial one-day jump and absence of announced news is common in lower-liquidity or micro-cap securities, where price discovery can be driven by technical factors such as options expiry, short squeeze activity, or algorithmic rebalancing rather than fundamental information. Alternatively, material news may have circulated through channels not captured by the Yahoo Finance RSS feed, or the market may be reacting to delayed information from an earlier day. Without access to the company's news releases, SEC filings, or proprietary data feeds, attributing this move to a specific business event would be speculation.

LBGJ

Li Bang International Corporation Inc. Ordinary SharesIndustrials

$1.02+$0.23

+29.1%

NASDAQ · Mkt cap $58 K

No news headlines were found in the last 48 hours, so the 29% jump on LBGJ cannot be attributed to a specific announced event. The move likely reflects technical trading, short covering, or undisclosed market activity in a low-liquidity micro-cap stock.

LBGJ experienced a sharp 29% single-day gain with zero corroborating news in the available 48-hour window. For a stock trading near $1, this type of volatility is common among micro-cap and penny stocks where low float, thin liquidity, and retail retail trading can amplify price swings on minimal volume or momentum. Possible drivers include short covering by holders of losing positions, accumulation by retail traders on technical signals, options-related hedging adjustments, or a delayed news item not yet picked up by the RSS feed. Without access to intraday volume, float data, short interest, or additional news sources, pinpointing the catalyst is not feasible from the provided evidence alone.

WKHS

Workhorse Group Inc.Consumer Cyclical

$4.07+$0.89

+28.0%

NASDAQ · Mkt cap $36 M

Workhorse announced a partnership with InCharge Energy to provide enhanced customer support across North America, likely driving optimism about operational improvements and customer retention that boosted the stock 28% intraday.

The partnership announcement with InCharge Energy centers on professional-grade customer support infrastructure spanning vehicle diagnostics, charging hardware, and software platforms. For a capital-intensive EV manufacturer like Workhorse, improved after-sales support and problem resolution can reduce warranty costs, improve customer satisfaction, and differentiate the product offering in a competitive market. The timing and specificity of the announcement—naming a dedicated support partner and highlighting multi-platform coverage—suggests management confidence in scaling operations. However, a 28% single-day gain on a support partnership alone is substantial and suggests either market expectation was very low, the announcement surprised positively in scope or timing, or the market is interpreting it as a sign of broader business stabilization or incoming positive catalysts.

NNE

Nano Nuclear Energy IncIndustrials

$29.07+$6.30

+27.7%

NASDAQ · Mkt cap $948 M

Nano Nuclear Energy surged 27.67% following announcement of a strategic partnership with Supermicro to supply advanced microreactors for AI data centers, coinciding with Supermicro's own 18% earnings rally on nuclear-powered infrastructure vision.

On May 6, Nano Nuclear announced a strategic memorandum of understanding with Supermicro, pairing its microreactor technology with Supermicro's AI server infrastructure to address data center energy demands. This partnership announcement arrived the same day Supermicro reported a significant earnings beat, raised full-year guidance, and explicitly highlighted a nuclear-powered AI vision in its forward guidance. The combination of concrete commercial validation through a named partnership with a major AI infrastructure player, coupled with Supermicro's enthusiastic endorsement and strong earnings, likely catalyzed the move. The nuclear sector was also buoyed by an Oklo-related milestone mentioned in sector coverage, which lifted several nuclear peers. Energy stocks overall fell 3.8% that afternoon, so the outperformance reflects company-specific and sector rotation strength rather than broad energy momentum.

ARMG

Leverage Shares 2x Long ARM Daily ETF

$21.95+$4.71

+27.3%

NASDAQ

No news headlines are available in the last 48 hours. ARMG is a 2x leveraged long ETF on ARM Holdings, so a +27.32% jump most likely reflects a sharp rally in ARM stock itself, which would have gained roughly 13-14% on an underlying fundamental catalyst or market shift.

The absence of news in the provided feeds does not mean no catalyst occurred; it simply means none is visible in this data snapshot. ARMG is a daily reset leveraged ETF that tracks ARM Holdings (NASDAQ: ARM) with 2x daily leverage, so its price moves are mechanically amplified versions of ARM's moves. A +27.32% gain in ARMG implies ARM rose approximately 13-14% on May 6, 2026. This magnitude of move for ARM typically correlates with earnings surprises, sector-wide semiconductor rallies, major contract announcements, analyst rating upgrades, or macroeconomic shifts affecting semiconductor demand or valuation. Without the actual ARM headlines or market context for May 6, 2026, the specific trigger cannot be identified from the evidence provided, though the move is substantial enough to warrant a major fundamental or technical catalyst rather than noise.

COMP

Compass, Inc.Real Estate

$9.24+$1.98

+27.3%

NYSE · Mkt cap $8.5 B

Compass reported Q1 2026 earnings that beat expectations significantly, with record adjusted EBITDA and early momentum from the Anywhere transaction closing, driving the 27% jump.

Compass released Q1 2026 financial results on May 5-6, 2026 that exceeded Wall Street estimates. The headlines establish that the company delivered an earnings surprise of plus 118 percent and a revenue surprise of plus 0.94 percent. Beyond the beat itself, management highlighted accelerated cost synergy plans, record first-quarter adjusted EBITDA, and operational momentum following the January 9 closing of the Anywhere transaction. While one headline notes the company is "out of its growth era" with some contraction in certain areas, the overall tone from executives and market reaction centered on the profitability beat and synergy execution. The stock's 27 percent gain ranks it as the 27th biggest gainer of the day, consistent with a significant positive earnings surprise in a real estate services company where investors had likely feared deteriorating margins post-acquisition integration.

BXC

BlueLinx Holdings Inc.Industrials

$58.70+$12.51

+27.1%

IFRX

InflaRx N.V.Healthcare

$2.50+$0.53

+26.9%

NASDAQ · Mkt cap $321 M

InflaRx announced a $150 million share offering and advancement of its lead drug izicopan into ANCA-associated vasculitis, likely signaling clinical confidence and capital for development despite dilution from the equity raise.

The stock jumped 26.9% on two simultaneous announcements. The share offering of $150 million would typically be viewed as dilutive and could depress stock price, but it was paired with clinical advancement news: the company is progressing izicopan into ANCA-associated vasculitis and other renal diseases, framed around a Capital Markets Day. This combination suggests investors interpreted the capital raise as enabling meaningful clinical progress in new indications rather than a sign of financial distress. For a small-cap biotech company, securing $150 million in new capital while announcing pipeline expansion into life-threatening disease areas can signal renewed momentum and de-risk the program. The market appears to have focused on the clinical optionality and funding runway rather than near-term dilution.

OCG

Oriental Culture Holding Ltd.Consumer Cyclical

$2.14+$0.45

+26.6%

NASDAQ · Mkt cap $3.4 M

No news headlines were found in the last 48 hours, so the 26.63% intraday jump in OCG likely stems from technical trading activity, short covering, or an unindexed announcement not yet reflected in public financial news feeds.

The absence of any headlines in the Yahoo Finance RSS feed over the past two days makes it difficult to pinpoint a fundamental catalyst for OCG's sharp gain. A jump of this magnitude in a lower-priced stock trading on NASDAQ can occur from several mechanisms: short squeeze activity if the stock had high short interest, technical breakout trading triggered by moving average crossovers or volume spikes, general retail momentum in microcap or culturally-themed equities, or a material corporate announcement that has not yet been picked up by major news aggregators. Without visibility into earnings surprises, analyst upgrades, business developments, or market-moving events specific to Oriental Culture Holding, we cannot establish a clear fundamental link to the price action. The lack of news is itself notable and suggests either a purely technical driver or a delay in news dissemination.

PYXS

Pyxis Oncology, Inc.Healthcare

$2.30+$0.47

+25.7%

NASDAQ · Mkt cap $214 M

No news about PYXS itself was provided; the only headline concerns a competitor (NanoViricides), so the 25.68% gain likely reflects sector momentum, technical rebound, or a delayed market reaction to unreported company-specific news.

The single news item in the feed is about NanoViricides receiving orphan drug designation for a measles treatment, which is unrelated to Pyxis Oncology. This suggests either the news provided is incomplete or the move was driven by factors other than the headlines listed. Small-cap biotech stocks like PYXS (trading at $2.30) are highly sensitive to clinical trial data, FDA decisions on their own programs, partnership announcements, or sector-wide sentiment shifts around oncology or immunotherapy. The orphan drug designation for a competitor could theoretically lift the sector, but that would be indirect. More likely explanations include a clinical update, financing news, or technical reversal in a previously depressed stock, none of which appear in the available headlines.

BUUU

BUUU Group Limited Class A Ordinary ShareIndustrials

$22.80+$4.63

+25.5%

NASDAQ · Mkt cap $474 M

No news headlines were found in the last 48 hours, so the +25.48% jump cannot be directly attributed to a disclosed catalyst. The move is likely driven by technical trading, a delayed announcement, or market rumor.

Yahoo Finance returned no news headlines for BUUU Group Limited in the 48 hours surrounding this snapshot, which is notable given the stock's 25.48% single-day gain and ranking as the 32nd biggest gainer on NASDAQ. Without access to the underlying reason for the move, plausible categories include: delayed earnings or guidance release that may have hit wire services outside the RSS feed window; a technical bounce or short squeeze if the stock carries a meaningful short interest; or announcement of a corporate action, partnership, or business development that has not yet appeared in major financial news aggregators. Chinese-listed companies like BUUU Group can sometimes experience price movements tied to regulatory changes, listing status updates, or regional news that filters into US markets with a lag. Without corroborating headlines, none of these remain more than inference.

POM

POMDOCTOR LtdHealthcare

$0.49+$0.10

+25.2%

NASDAQ · Mkt cap $7.0 M

No news headlines were found in the last 48 hours, so the 25% gain on May 6 lacks a documented catalyst. The move is likely driven by technical factors, retail interest, or undisclosed material information.

POM's 25% single-day jump occurred without any identified news in the Yahoo Finance RSS feed over the preceding 48 hours. This absence of documentation does not rule out a catalyst—material events sometimes spread through other channels before appearing in major headlines, or trading activity itself can attract retail attention in smaller-cap names. Without visibility into the stock's fundamentals, short interest levels, or trading volume, reasonable hypotheses include a delayed earnings release, analyst upgrade, clinical or regulatory development for a healthcare-related entity, insider buying signal, or simply momentum-driven accumulation by retail investors. The stock's low price point and rank among top gainers suggests it may be trading on sentiment or technicals rather than broad-based institutional repositioning.

VECO

Veeco Instruments Inc.Technology

$62.01+$12.47

+25.2%

NASDAQ · Mkt cap $2.6 B

Veeco announced $250M+ in equipment orders for indium phosphide laser manufacturing alongside positive forward guidance tied to AI infrastructure demand, offsetting Q1 earnings and revenue misses that triggered the initial selloff.

Veeco reported Q1 results that missed earnings by 30% and revenue slightly, which would typically pressure the stock downward. However, the company simultaneously announced a major $250M+ equipment order win from multiple customers for its Spector, Lumina, and Wet Processing Systems. Management's earnings call emphasized rising multi-year demand driven by artificial intelligence and high-performance computing infrastructure needs. The company issued Q2 guidance within expected ranges rather than cutting outlook. The combination of a substantial backlog announcement and management's confidence in secular AI-driven demand appears to have reversed the initial negative reaction to the earnings miss, suggesting investors are viewing the order win and forward positioning as more material than the quarterly shortfall.

TBH

Brag House Holdings, Inc.Technology

$0.68+$0.14

+25.0%

VCYT

Veracyte, Inc.Healthcare

$41.19+$8.22

+24.9%

NASDAQ · Mkt cap $3.6 B

Veracyte reported a strong Q1 2026 earnings beat with a +52.94% earnings surprise and +6.60% revenue beat, driven by double-digit growth in revenue and test volume, along with improved profitability, triggering the 24.93% stock surge.

On May 5-6, 2026, Veracyte announced Q1 2026 financial results that exceeded analyst expectations on both the bottom and top lines. The earnings surprise of 52.94% represents a substantial outperformance, while the revenue beat of 6.60% demonstrates solid topline growth. Management characterized the quarter as an "excellent start" to the year, emphasizing double-digit growth in both revenue and test volume alongside improved profitability metrics. The timing of the earnings call and multiple news articles covering the announcement on May 5-6 align precisely with the stock's 24.93% gain on May 6. Additionally, Wall Street analysts' average price target implies 39.16% potential upside, suggesting analyst confidence in the company's trajectory post-results.

CHARR

Charlton Aria Acquisition Corporation

$0.10+$0.02

+24.7%

NASDAQ

No news headlines were found in the last 48 hours, so the 24.69% gain cannot be attributed to any reported corporate event or market announcement. The move is likely driven by technical, speculative, or rumor-based trading.

CHARR is a blank-check acquisition company (SPAC), a security class historically prone to volatile price swings on minimal or no fundamental catalysts. With zero news in the headline feed, the jump from $0.08 to $0.10 per share could reflect several plausible but unverified scenarios: a delayed press release not yet indexed by the news aggregator, social media speculation or retail momentum, options-related positioning, or short covering. SPACs often trade on rumor of merger targets or insider activity before formal announcements. Without access to intraday order flow, after-hours activity, or social media sentiment, attributing the move to any specific cause would be speculation. The stock's very low price point and SPAC structure make it sensitive to even small absolute dollar flows.

TBLA

Taboola.com Ltd.Communication Services

$4.75+$0.94

+24.7%

NASDAQ · Mkt cap $1.0 B

Taboola crushed Q1 earnings expectations with revenue beating estimates and raised full-year guidance, triggering the 24.67% rally as investors repriced the stock higher on accelerating growth momentum.

Taboola reported first-quarter 2026 results that exceeded Wall Street consensus on both revenue and earnings. Multiple sources confirm revenue of $466.4 million beat expectations with 9.1% year-over-year growth, while the company delivered an earnings surprise and raised its full-year outlook. The guidance raise is particularly significant as it signals management confidence in accelerating growth ahead, not just a one-quarter beat. Investors typically respond strongly to positive earnings surprises combined with upwardly revised forward guidance, especially in growth-oriented stocks. The content discovery platform appears to have demonstrated stronger advertising business performance and operational momentum than the market had priced in before the announcement. No offsetting negative news appears in the headlines.

SRFM

Surf Air Mobility Inc.Industrials

$1.37+$0.27

+24.5%

NYSE · Mkt cap $85 M

Surf Air Mobility announced details of its SurfOS commercial launch plan on May 6, which likely drove the 24.55% gain as investors reacted positively to the AI-enabled software platform's go-to-market strategy.

The only news headline directly relevant to SRFM is the May 6 announcement regarding SurfOS commercial launch details. The headline confirms the company provided specifics on its go-to-market strategy for SurfOS, described as an AI-enabled software operating system. This appears to be a substantive corporate announcement rather than routine news. The timing matches the stock move precisely (announcement at 10:55 UTC on the same day as the recorded price jump), suggesting investor enthusiasm for the commercialization plan. The market may have interpreted the announcement as validation of the company's AI software direction and revenue diversification strategy. The other two headlines reference different airlines and are unrelated to SRFM's business.

SMCI

Super Micro Computer, Inc.Technology

$34.66+$6.83

+24.5%

NASDAQ · Mkt cap $26 B

Super Micro Computer surged 24.54% after reporting a margin-driven earnings beat, raising full-year guidance, and benefiting from surging AI data center demand, though revenue missed expectations.

The headlines establish that SMCI reported Q3 fiscal 2026 results on May 5 after market close, beating earnings estimates but missing on revenue. The key driver of the +24.54% rally appears to be margin recovery and guidance strength rather than top-line growth. Adjusted gross margin reached 10.1% in the quarter, exceeding estimates, and management issued a rosy outlook for the June quarter with profit guidance above consensus. Multiple sources highlight that despite the revenue miss, investors focused on the margin improvement and strong AI data center demand tailwinds. The company makes AI-optimized servers and datacenter infrastructure, positioning it to benefit from the ongoing generative AI buildout. One headline notes the stock had been trading relatively flat despite revenue doubling year-over-year, suggesting the market may have been waiting for profitability confirmation, which the margin beat and raised guidance provided. The rally also occurred amid broader strength in semiconductor and AI-related stocks, with AMD mentioned as surging on demand signals from CEO Lisa Su.

MNKD

MannKind CorporationHealthcare

$3.56+$0.70

+24.5%

NASDAQ · Mkt cap $1.3 B

MannKind reported Q1 2026 revenues of $90.2M (up 15% year-over-year) on the same day it announced a new ralinepag dry powder inhalation program with United Therapeutics and a $5 million payment, likely driving the 24.48% gain.

The stock jumped on what appears to be a combination of better-than-expected quarterly results and positive pipeline catalysts. The Q1 revenue figure of $90.2M with 15% growth year-over-year suggests the company is executing on its commercial strategy for Afrezza. Simultaneously, the announcement of the ralinepag DPI program collaboration with United Therapeutics, backed by an additional $5 million milestone payment, signals new revenue streams and validates the company's technology platform beyond its current marketed product. Small-cap biotech stocks often respond sharply to earnings beats paired with partnership validation and cash infusions, as these reduce execution risk and extend the investment runway. The timing of both announcements on the same day created a compounding positive catalyst that likely triggered the 24% move.

TEAD

Teads Holding Co.Communication Services

$1.15+$0.22

+23.6%

NASDAQ · Mkt cap $61 M

Teads announced a strategic partnership with Lumen Research to integrate attention science into connected TV advertising, offering advertisers omnichannel measurement capabilities that likely drove the 23.59% gain.

The headline published on May 6 describes a new product integration between Teads and Lumen Research focused on connected TV (CTV) advertising with attention science validation and omnichannel optimization. This is a concrete partnership announcement that expands Teads' addressable market in the high-growth CTV space and provides measurable differentiation versus competitors. For an advertising technology company trading at a modest market cap, a new distribution partnership with validated measurement science typically signals revenue diversification and competitive moat strengthening. The timing of the announcement on the same day as the price spike suggests the market is pricing in incremental value from this integration, particularly for advertisers seeking unified metrics across channels. No earnings, guidance, or acquisition details are provided in the headline, so the move reflects investor enthusiasm for the strategic positioning rather than financial results.

GDXU

MicroSectors Gold Miners 3X Leveraged ETNFinancial Services

$191.09+$36.40

+23.5%

AMEX

No news headlines were available in the last 48 hours, but the 23.53% gain in this 3x leveraged gold miners ETN likely reflects a sharp rally in the underlying gold mining sector, possibly driven by gold price strength or broader commodity market moves.

No headlines appeared in the Yahoo Finance RSS feed for the last 48 hours, so there is no identifiable company-specific or sector news to point to. However, GDXU is a 3x leveraged ETN tracking gold mining equities, which means it amplifies intraday moves in its underlying index by triple. A 23.53% jump in a 3x leveraged vehicle suggests roughly an 8% move in the underlying gold miners index. This kind of move is typical when gold prices surge sharply (driven by inflation concerns, Fed policy shifts, geopolitical risk, or currency weakness) or when there is a broad commodity rally. Without access to gold prices or broader market context for May 5-6, 2026, the most likely explanation is an exogenous move in precious metals or macro sentiment that lifted the entire gold mining complex.

ATYR

aTyr Pharma, Inc.Healthcare

$1.04+$0.20

+23.5%

NASDAQ · Mkt cap $52 M

No news was found in the last 48 hours, so the 23.49% gain cannot be directly attributed to a specific disclosed catalyst. The move may reflect technical factors, delayed market reaction to older news, or undisclosed company developments.

The absence of recent news headlines makes it impossible to pinpoint a definitive cause for aTyr Pharma's strong single-day gain. aTyr is a clinical-stage biopharmaceutical company, and such stocks are particularly sensitive to clinical trial updates, regulatory decisions, financing announcements, or strategic partnerships. Given the lack of disclosed information, the move could reflect several possibilities: a delayed market reaction to news released outside the 48-hour window, technical buying or short covering, sector rotation into biotech, insider accumulation ahead of unreported news, or pure momentum trading. Without access to press releases, SEC filings, or broader market context for the snapshot date, attribution remains speculative.

DVA

DaVita Inc.Healthcare

$193.88+$36.84

+23.5%

GLWG

Leverage Shares 2X Long GLW Daily ETF

$26.68+$5.04

+23.3%

NASDAQ

No news headlines were found in the last 48 hours; however, GLWG is a 2X leveraged ETF tracking Corning Inc (GLW), so a 23.29% gain likely reflects a strong move in the underlying stock amplified by the fund's 2X daily leverage mechanism.

The absence of news headlines makes it impossible to identify a specific catalyst from reported events. However, GLWG's structure provides a concrete explanation for the magnitude of the move. GLWG is designed to deliver twice the daily return of Corning Inc stock. A 23.29% gain in GLWG implies the underlying GLW rose approximately 11-12% on the day, which would warrant investigation into Corning-specific catalysts such as earnings beats, positive guidance, semiconductor or optical technology announcements, or broader tech sector strength. Without those headlines in the provided feed, the specific cause remains unknown, but the leveraged structure of this ETF ensures outsized moves relative to its underlying equity whenever GLW experiences significant daily swings.

HOVR

New Horizon Aircraft Ltd.Industrials

$2.81+$0.53

+23.2%

NASDAQ · Mkt cap $132 M

A scheduled investor webinar announcement on May 6th coinciding with the stock's 23% single-day surge suggests the market expects meaningful news or updates to be revealed during the May 7th live Q&A session, though the webinar itself does not disclose specific catalysts.

The only headline provided is an announcement of an upcoming investor webinar hosted by RedChip Companies featuring New Horizon Aircraft management on May 7th at 4:15 p.m. ET. The timing of this announcement on May 6th aligns with the day's strong rally, suggesting investor anticipation ahead of the event. However, the press release contains no new operational, financial, or strategic information—it is merely promotional notification of the webinar itself. The 23% gain likely reflects either pre-event optimism that management will disclose positive news during the Q&A, or possibly broader market enthusiasm for the company's prospects independent of this specific announcement. Without details about what will be discussed or any recent material developments, the exact catalyst remains unclear. This type of move in a small-cap aircraft manufacturer stock could also reflect technical factors, short covering, or market sentiment shifts unrelated to the webinar.

CVGI

Commercial Vehicle Group, Inc.Consumer Cyclical

$5.20+$0.98

+23.2%

NASDAQ · Mkt cap $121 M

CVGI surged 23.22% following Q1 earnings released on May 5-6, where the company beat revenue estimates by 7.18%, returned to year-over-year revenue growth, and raised adjusted EBITDA while reaffirming full-year guidance.

Commercial Vehicle Group reported first-quarter 2026 results that exceeded Wall Street expectations on the top line, posting $171.5 million in revenue against consensus estimates, representing 1% year-over-year growth and a return to consolidated revenue growth. The company also delivered a 28.57% earnings surprise with EPS of $0.03, posted adjusted EBITDA of $4.8 million, and demonstrated margin improvement driven by strength in Global Electrical Systems and Global Seating segments. Management reaffirmed full-year guidance and announced a sale-leaseback transaction to accelerate leverage reduction. While the prior CFO's departure on April 1 could be a minor negative, the earnings beat, margin expansion, and credible forward guidance appear to have dominated investor sentiment, driving the outsized single-day gain typical of small-cap industrials responding to positive surprises.

KBDU

KraneShares 2X Long BIDU Daily ETFFinancial Services

$31.46+$5.90

+23.1%

NASDAQ

No news headlines were published in the last 48 hours, but KBDU is a 2X leveraged long ETF tracking Baidu, so a +23.09% gain likely reflects a sharp rally in the underlying BIDU stock, amplified by the fund's 2X daily reset mechanism.

No recent news is available to identify a specific catalyst for this move. However, KBDU's structural design provides a clear explanation framework. This is a leveraged daily reset ETF holding approximately 2X long exposure to Baidu (BIDU). A roughly 11-12% gain in BIDU would translate to approximately the observed 23% move in KBDU after accounting for leverage and daily rebalancing mechanics. Since no headline catalyst appears in the last 48 hours, the underlying move in BIDU itself may have been driven by several typical categories: positive earnings or guidance from Baidu, favorable sentiment shifts in Chinese tech stocks, broader market rally effects, technical bounces, or undisclosed corporate developments that had not yet been syndicated to Yahoo Finance RSS feeds at the snapshot date.

UUUG

Leverage Shares 2x Long UUUU Daily ETF

$15.73+$2.91

+22.7%

NASDAQ

No news headlines were found in the last 48 hours, but UUUG is a 2x leveraged ETF tracking UUUU, so the +22.72% gain most likely reflects a substantial move in the underlying stock amplified by the leverage.

UUUG is a daily reset leveraged ETF designed to deliver 2x the daily return of its underlying index or security. With no news available in the provided headlines, the move cannot be attributed to a specific announced event affecting UUUG or its sponsor. However, the structure of this security suggests the most probable explanation: the underlying security or index (UUUU) experienced a significant single-day gain of approximately 11% or more, which the 2x leverage mechanically amplified to the observed +22.72%. This type of ETF is sensitive to intraday volatility and underlying asset performance. Without news on UUUU itself, the cause could be technical rebound, short covering, sector rotation, or delayed market reaction to an earlier announcement, but those remain inference rather than established fact.

Biggest Losers

Wed, May 6, 2026 50

EZGO

EZGO Technologies Ltd.Consumer Cyclical

$0.16−$1.74

-91.6%

NASDAQ · Mkt cap $2.6 M

No news headlines were reported in the last 48 hours, so the 91.58% crash in EZGO cannot be directly attributed to a specific disclosed event; the move likely reflects either a delayed market reaction to prior negative news, a significant delisting warning, or severe liquidity/technical selling a…

The complete absence of recent news headlines combined with an extraordinary single-day loss of over 91% suggests this is not a reaction to breaking company-specific news. EZGO is a micro-cap stock trading at $0.16, making it highly susceptible to several non-news-driven catalysts: (1) a critical delisting warning or announcement from NASDAQ regarding listing standards compliance, which would not always appear in standard financial news feeds immediately; (2) a short squeeze reversal or momentum-driven selling panic in a thinly traded security; (3) a delayed market repricing following earlier disclosed problems such as failed financing, failed product launch, or regulatory action that Yahoo Finance's 48-hour window may not have captured. Without access to NASDAQ exchange notices or company filings from the past week, the specific trigger cannot be identified from available evidence.

GDC

GD Culture Group LimitedCommunication Services

$1.24−$4.75

-79.3%

NASDAQ · Mkt cap $7.8 M

GD Culture Group received a preliminary non-binding going-private proposal at $10.75 per share on May 5, but the stock collapsed 79% to $1.24 by May 6, suggesting the market views the offer as significantly undervaluing the company or faces serious doubts about deal viability.

The headlines reveal that GD Culture's board received a preliminary non-binding going-private offer at $10.75 per share on May 5, followed immediately on May 6 by formation of a special committee to evaluate it. The 79% plunge from that offer price to $1.24 is counterintuitive and alarming. Normally, a going-private proposal at a stated price acts as a floor for the stock. The catastrophic sell-off suggests either the market believes the offer will not close, the offeror lacks financing credibility, or undisclosed negative information about the company has emerged. Alternatively, the headline text may be truncated and missing critical details about deal conditions, financing contingencies, or accompanying bad news that would explain the severe repricing downward.

PRIM

Primoris Services CorporationIndustrials

$101.37−$101.56

-50.0%

NYSE · Mkt cap $4.2 B

Primoris crashed 50% after reporting Q1 2026 earnings that badly missed expectations, with revenue down 5.4% year-over-year and earnings down 40%, compounded by cautious guidance on project timing despite broader optimism about solar markets.

The earnings miss on May 5th is the clear catalyst. Primoris reported Q1 2026 revenue of $1.56 billion, falling 5.4% year-over-year and missing consensus estimates by 10%. More critically, non-GAAP earnings of $0.59 per share fell 40% and missed by 32%, a severe shortfall. Management acknowledged challenges tied to a limited project pipeline and delays in new project starts, though they expressed optimism about solar market fundamentals. The stock initially dropped 29-31% on May 5th in after-hours trading and continued lower on May 6th, suggesting the market is pricing in not just one quarter of weakness but concern about the trajectory and timing of project execution in the pipeline. This is particularly notable because competitors like Sterling Infrastructure apparently beat expectations in the same period, implying PRIM's miss was company-specific rather than sector-wide.

SMCZ

Daily Target 2X Short SMCI ETF

$13.29−$12.87

-49.2%

NASDAQ

No news headlines were found in the last 48 hours, but SMCZ is a 2X inverse leveraged ETF tracking Super Micro Computer (SMCI), so a -49% drop in SMCZ almost certainly reflects a sharp rally in SMCI itself, not negative SMCI news.

SMCZ is designed to move in the opposite direction of SMCI with 2X daily leverage, meaning if SMCI surged approximately 25% or more on the day, SMCZ would decline by roughly 50%. No recent news headlines were provided for SMCI or the broader market, so the specific catalyst for SMCI's apparent rally is not identified here. However, this type of inverse leveraged ETF is extremely sensitive to moves in its underlying stock. The move is mechanically consistent with strong performance by SMCI rather than a structural failure or discount widening in SMCZ itself. Without headlines, we cannot determine whether SMCI's rally was driven by earnings, guidance, sector momentum, short covering, or broader tech strength, but the magnitude and direction of SMCZ's loss is entirely expected behavior for this security on a strong SMCI day.

AMPGZ

Amplitech Group, Inc. Series B Right

$0.05−$0.04

-44.3%

NASDAQ

No news headlines were found in the last 48 hours to explain the 44% decline in AMPGZ, so the cause cannot be definitively established from available information.

AMPGZ is a Series B Right offering from Amplitech Group, a specialized security instrument tied to a rights offering rather than ordinary equity. The 44% single-day drop with zero news coverage in the past two days suggests either a technical event specific to rights offerings, execution of redemption or expiration mechanics, a market-wide technical correction in micro-cap securities, or delayed reporting of company news not yet reflected in the Yahoo Finance RSS feed. Rights offerings are volatile instruments with built-in time decay and specific exercise windows, so calendar-driven moves or the approach of expiration dates are plausible. Alternatively, negative company news or broader market stress affecting micro-cap illiquid securities could be responsible, but without headlines this remains inference only.

ONEG

OneConstruction Group LimitedIndustrials

$6.56−$4.40

-40.1%

NASDAQ · Mkt cap $16 M

OneConstruction Group fell 40.15% on May 6, 2026, but no news headlines are available in the last 48 hours, making the specific catalyst impossible to identify from public reporting.

The absence of any reported headlines in the last two days suggests the trigger for this severe decline either occurred outside the covered news window, spread primarily through non-traditional channels, or represents a delayed market reaction to an earlier announcement. For a construction-focused company trading on NASDAQ, typical catalysts for such sharp declines would include missed earnings or negative guidance, loss of a major contract, project delays or cost overruns, adverse regulatory or safety findings, covenant breaches on debt, or management changes. Without access to the actual news that preceded this move, any explanation remains speculative. The 6th-place ranking among daily losers indicates this was a market-wide event-driven day, but whether ONEG's drop stems from company-specific versus sector-wide pressures cannot be determined from the available evidence.

PHOE

Phoenix Asia Holdings Limited Ordinary SharesIndustrials

$28.60−$18.39

-39.1%

NASDAQ · Mkt cap $526 M

Phoenix Asia Holdings announced entry into a stock acquisition agreement and convertible promissory note on May 4, followed by a related Scilex subsidiary deal announcement on May 5, likely triggering shareholder concerns about dilution or unfavorable terms that drove the 39% single-day collapse.

Two related announcements appeared within 48 hours: Phoenix Asia disclosed a stock acquisition agreement and convertible promissory note on May 4, and the next day Scilex announced that its subsidiaries ACEA Therapeutics and ACEA Pharma had entered into a definitive agreement with Phoenix Asia. The headlines provided do not specify deal terms, valuation, dilution ratios, or whether the convertible note pricing was at a discount to market. However, the timing and sequence suggest a material corporate transaction. For a stock to drop 39% in one day following deal news, typical catalysts include large share issuance dilution, below-market conversion pricing on the debt, loss of control provisions, or market perception of poor value received. Without full disclosure of terms, we cannot pinpoint the exact mechanism, but the correlation between the announcement window and the collapse is strong.

WHLR

Wheeler Real Estate Investment Trust, Inc.Real Estate

$1.19−$0.73

-38.0%

NASDAQ · Mkt cap $942 K

No news headlines were published in the last 48 hours, so the cause of the 38% drop cannot be determined from available reporting. The decline likely stems from company-specific developments, broad market factors, or rumors not yet covered by major outlets.

The absence of any news in the last 48 hours makes it impossible to pinpoint a specific catalyst for Wheeler Real Estate Investment Trust's sharp decline. Real estate investment trusts are sensitive to interest rate expectations, property valuations, and dividend sustainability concerns. A 38% single-day drop of this magnitude for a stock trading below $2 typically signals either a material negative announcement the market reacted to before news wires picked it up, a sudden shift in investor sentiment about the underlying properties or balance sheet, or a technical capitulation in a thinly traded name. Without headline confirmation, we cannot rule out delayed disclosure of poor quarterly results, covenant violations, dividend cuts, significant insider selling, or sector-wide contagion tied to commercial real estate stress.

ANGI

Angi Inc.Communication Services

$4.80−$2.61

-35.2%

NASDAQ · Mkt cap $195 M

Angi reported Q1 revenue that missed analyst expectations by 1.33% and posted a GAAP loss, triggering a 35% stock decline despite earnings-per-share beating estimates by 46%.

Angi released first-quarter 2026 earnings on May 5-6, 2026. The company missed revenue guidance with sales of $238.2 million, representing a 3.2% year-over-year decline and falling short of consensus forecasts. While the company beat on EPS (posting a loss smaller than feared), the revenue miss and declining sales trajectory appear to have been the primary catalyst for the sharp selloff. Management discussed a strategic pivot toward an "AI native" platform and AI agents, which may have been viewed by the market as insufficient to offset near-term revenue pressure or as a distraction from operational fundamentals. The combination of declining year-over-year sales, unmet revenue expectations, and ongoing losses likely overwhelmed the EPS beat in investor sentiment.

APUS

Apimeds Pharmaceuticals US, IncHealthcare

$1.95−$1.05

-35.0%

AMEX · Mkt cap $6.0 M

Apimeds announced a settlement with Inscobee and a merger to proceed with a $100 million PIPE financing, but the stock plunged 35% on what should have been positive news, suggesting investor concerns about deal terms, dilution, or execution risk outweighed the headline.

The headline from May 5 announces what appears to be constructive developments: a settlement resolving disputes, merger clearance, and secured $100 million PIPE financing to fund the combined entity's operations and the Apitox program advancement. Normally, such announcements with committed capital would support the stock. However, the 35% same-day drop suggests the market either views the settlement terms as unfavorable to existing shareholders, fears significant dilution from the PIPE at a low valuation, or has lost confidence in the merger rationale or management's ability to execute. Without access to the full press release details, deal terms, or investor call commentary, the exact source of selling pressure cannot be pinpointed, but the magnitude of the decline indicates deep shareholder disappointment with either the economics or strategic direction revealed in the announcement.

LMB

Limbach Holdings, Inc.Industrials

$76.97−$37.14

-32.5%

NASDAQ · Mkt cap $594 M

Limbach reported Q1 earnings that beat expectations and management highlighted strong bookings and accelerating demand, yet the stock plummeted 32.55%, suggesting investors either anticipated even stronger guidance, expressed concern about margin sustainability, or reacted to something disclosed …

The headlines establish that Limbach delivered a substantial earnings surprise of +130.63% and a modest revenue beat of +3.21% on May 5-6, 2026. Management reportedly pointed to accelerating demand and exceptionally strong bookings. Yet the stock dropped 10.5% immediately after earnings and another 22.05 percentage points since then, ranking it 11 biggest loser today. One headline notes the stock dropped 10.5% despite beating revenue expectations, suggesting the initial sell-off was not tied to missing the top or bottom line. The most plausible explanation is that either full-year guidance disappointed relative to market expectations, profitability concerns emerged during the call discussion, or the company signaled headwinds ahead that temper the near-term momentum. Without access to the full transcript details beyond the headline summaries, the precise catalyst remains partially obscured, but the magnitude of the decline relative to positive headline language points to either guidance conservatism or disclosure of operational risks during the live call.

KVYO

Klaviyo, Inc.Technology

$15.81−$7.53

-32.3%

NYSE · Mkt cap $5.9 B

Klaviyo reported strong Q1 2026 earnings with 28% revenue growth and a beats on both earnings and revenue, yet the stock plummeted 32% in one day, suggesting the market's reaction focused on forward guidance, margin concerns, or valuation rather than the beat itself.

The headlines confirm that Klaviyo delivered a solid quarter on May 5, 2026: revenue growth of 28%, an earnings beat of 13.4%, a revenue beat of 2.83%, record operating margins, and a raised full-year outlook. By conventional metrics, these results should support the stock price or lift it. The massive 32% single-day drop despite positive headlines points to a disconnect between reported results and either management's forward commentary, margin trajectory concerns disclosed on the call, or a valuation reset by the market. The earnings transcript and call summary are referenced but their specific content is not detailed in the headlines provided, leaving the precise reason for the market's rejection unclear. Reasonable inference is that guidance language, competitive commentary, customer concentration risk, or net-revenue-retention trends mentioned on the call triggered a sharp repricing downward despite headline-level beat metrics.

ATEC

Alphatec Holdings, Inc.Healthcare

$6.99−$3.24

-31.7%

NASDAQ · Mkt cap $1.4 B

Alphatec reported Q1 2026 revenue of $192 million (up 14% year-over-year) but fell short of internal expectations due to weaker-than-planned EOS performance, triggering a sharp 31.67% single-day sell-off.

Alphatec held its earnings call on May 5-6, 2026 and disclosed that while revenue grew 14% year-over-year and the company achieved break-even earnings (beating expectations on that metric), Q1 results missed the company's own internal quarterly goal. The shortfall was attributed specifically to underperformance in the EOS (presumably a key product line or segment). One headline noted a fund had disclosed selling $18 million in Alphatec stock in the prior quarter, suggesting some institutional confidence had already eroded. The company also announced a debt refinancing with a new bank facility on the same day, which in isolation could be neutral, but combined with earnings disappointment appears to have weighed on sentiment. The magnitude of the one-day drop (31.67%) suggests the market's reaction was severe, possibly reflecting concerns about execution, guidance revision, or broader confidence in management's ability to meet targets.

CRE

Cre8 Enterprise Limited Class A Ordinary SharesIndustrials

$2.76−$1.13

-29.0%

NASDAQ · Mkt cap $5.2 M

No news headlines were found in the last 48 hours, so the 29% drop cannot be attributed to a specific announced event; the cause likely falls into technical selling, market-wide pressure, or undisclosed company developments.

The absence of recent news headlines makes it impossible to pinpoint a concrete catalyst for CRE's steep 29% single-day decline. This magnitude of drop typically stems from several possible categories: earnings disappointment or missed guidance that may not yet be reflected in the news feed, sector-wide selling pressure affecting small-cap stocks, technical breakdown through key support levels triggering algorithmic selling, or company-specific negative developments not yet widely reported. For a smaller-cap NASDAQ stock like Cre8 Enterprise, liquidity events and insider activity can also amplify price moves. Without headline evidence, attribution remains speculative, though the ranking as the 14th biggest loser suggests broader market factors or a sector downturn may be at play alongside any company-specific issues.

TDWDR

Tailwind 2.0 Acquisition Corp. Rights

$0.12−$0.05

-28.1%

NASDAQ

No news headlines are available for the past 48 hours, so the 28% drop in this SPAC rights unit cannot be directly attributed to a reported event. The decline likely reflects either broader market weakness in blank-check securities, deteriorating merger prospects, or routine volatility in a low-p…

The absence of recent news makes direct causation impossible to establish. However, Tailwind 2.0 Acquisition Corp. Rights are a component of a SPAC structure, meaning this security's value depends critically on the underlying merger timeline and deal sentiment. Rights offerings typically trade on speculation about deal closure and the post-merger equity value. A sharp 28% single-day drop in a rights unit with no accompanying headline could reflect several typical catalysts: negative commentary or delay announcements about the pending merger (which may not yet have reached Yahoo's RSS feed), broader SPAC sector weakness, redemption announcements that signal investor skepticism, or deteriorating macroeconomic conditions affecting deal financing. Alternatively, the move could be technical selling in a thin, low-priced security. Without access to the actual merger target, deal status, or redemption data, the true driver remains speculative.

ANEL

Defiance Daily Target 2X Long ANET ETF

$17.26−$6.39

-27.0%

NASDAQ

No news headlines were found in the last 48 hours, but ANEL is a 2X leveraged ETF tracking Arista Networks (ANET), so a sharp drop likely reflects a decline in the underlying stock amplified by the leverage multiplier.

The absence of news in the provided headlines does not mean no catalyst occurred; it means the news source did not capture it within the 48-hour window. However, ANEL's structure provides a clear explanation mechanism. ANEL is a daily target 2X leveraged long ETF, meaning it aims to deliver twice the daily return of its underlying index or security. If ANET (Arista Networks) dropped roughly 13-14% on May 6th, a 2X leveraged product would amplify that move to approximately -27%, which aligns precisely with ANEL's observed decline. The cause likely originates with ANET itself, whether from earnings disappointment, guidance reduction, competitive pressure, sector weakness, or other company-specific or market-wide catalyst. Without specific headlines about ANET, we cannot pinpoint the exact driver, but the magnitude and direction of ANEL's move is mechanically consistent with leveraged amplification of an underlying decline.

HCKT

The Hackett Group, Inc.Technology

$10.21−$3.68

-26.5%

NASDAQ · Mkt cap $270 M

Hackett Group reported Q1 2026 earnings and revenue that missed analyst estimates by 1.93% and 5.31% respectively, citing macro-driven demand pressure and elongated client decision cycles, triggering the 26.49% stock decline.

The Hackett Group announced first-quarter 2026 financial results on May 5-6, 2026 that fell short of consensus expectations on both earnings per share and revenue. Management attributed the shortfall to macro-driven demand pressure and lengthened client decision cycles tied to broader market uncertainty. The news headlines confirm these misses were reported during the earnings announcement, and the 26.49% single-day decline is consistent with a significant earnings disappointment for a consulting and digital transformation firm. The magnitude of the drop suggests investors had expected better results or that guidance for forward periods may also have disappointed, though the excerpts provided do not include forward guidance detail.

KFIIR

K&F Growth Acquisition Corp. II Rights

$0.12−$0.04

-26.4%

NASDAQ

No news headlines were found in the last 48 hours to explain the 26.43% drop, but this is a SPAC rights offering—a security type that typically faces redemption pressure and liquidity challenges as parent entities approach business combination deadlines or dissolution.

KFIIR is a rights instrument issued by a Special Purpose Acquisition Company (SPAC), a structure that inherently carries execution risk tied to business combination timelines and shareholder redemption activity. Without news headlines, the decline most likely reflects one of two scenarios common to SPAC rights: either deteriorating sentiment around the parent SPAC's ability to complete a merger or announcement of a redemption event, extension deadline, or dissolution timeline. SPAC rights are junior securities whose value decays as the window for a business combination closes. The magnitude of the drop (over 26%) suggests a material event affecting redemption odds or deal certainty, even if no public headline has surfaced yet in the RSS feed lag. Alternatively, the decline could reflect technical selling linked to the underlying SPAC's share price weakness.

BWEN

Broadwind, Inc.Industrials

$1.98−$0.71

-26.4%

NASDAQ · Mkt cap $115 M

Broadwind announced a strategic exit from the wind market through sale of its Abilene facility and withdrew 2026 financial guidance, signaling a major pivot away from its core business and triggering a 26% sell-off.

On May 5, 2026, Broadwind announced it is selling its Abilene facility and exiting the wind market entirely, repositioning itself as a pure-play precision manufacturer for power generation and critical infrastructure. Simultaneously, the company withdrew its 2026 financial guidance. This combination of moves—divesting a major asset, abandoning a historical market segment, and pulling forward guidance—signals significant uncertainty about near-term earnings and strategic direction. Investors typically interpret such announcements as warnings of weak near-term performance and management's lack of confidence in prior projections. The magnitude of the decline (26% in one day) reflects the market's perception that this is a major negative shift requiring repricing of the company's outlook and valuation multiples.

SOBR

SOBR Safe, Inc.Technology

$1.03−$0.36

-25.9%

NASDAQ · Mkt cap $1.6 M

No news headlines were available in the last 48 hours to explain SOBR's 25.90% drop, making the cause unclear without additional context or research into intraday developments.

The absence of any news coverage in the past two days is notable for a stock experiencing such a sharp decline, ranking as the 20th largest loser on the exchange. This suggests either that the catalyst was a technical or market-wide event, an intraday rumor or social media-driven sell-off, a delayed reaction to older news, or a company-specific development not yet picked up by major news feeds. SOBR is a small-cap stock in the alcohol monitoring and safety technology space, which can be subject to higher volatility and lower news coverage density. Without headlines directly linked to earnings, guidance, regulatory action, or corporate announcements, the specific trigger cannot be identified from the information provided.

AZTA

Azenta, Inc.Healthcare

$18.38−$6.23

-25.3%

NASDAQ · Mkt cap $1.4 B

Azenta reported Q2 2026 fiscal results that missed expectations due to execution shortfalls and weak North American demand, prompting a sharp 25% sell-off on the day of earnings disclosure.

On May 6, 2026, Azenta reported second-quarter fiscal 2026 results that management explicitly stated fell short of expectations. The primary drivers cited were execution shortfalls within the company and a cautious demand environment, with particular weakness noted in North America. The earnings call highlights and full-year guidance update were released simultaneously, suggesting management also adjusted forward expectations downward or issued cautious guidance. A 25% single-day drop is consistent with a significant earnings miss combined with reduced full-year guidance, especially if the North American market weakness signals broader demand deterioration. The timing of three earnings-related headlines on May 5-6 confirms this was the primary catalyst for the decline.

GDXD

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

$35.03−$10.92

-23.8%

AMEX

No news headlines found in the last 48 hours. GDXD is a -3X inverse leveraged ETN on gold miners, so a 23.77% decline most likely reflects a sharp rally in gold prices or gold mining stocks, which would move this inverse product sharply downward.

The absence of any news in the provided headlines makes it impossible to point to a specific catalyst. However, GDXD's structure is key: as a -3X inverse leveraged ETN, it moves in the opposite direction of the underlying gold miners index with 3X leverage. A sustained rise in gold prices or gold mining equities would push this instrument down. Given gold's status as a macro-sensitive asset class, possible drivers of an upward move in the underlying could include shifts in interest rate expectations, geopolitical risk demand, or currency weakness. Without direct evidence, this remains inference based on the security's mechanical relationship to its underlying rather than a confirmed news event.

TMDX

TransMedics Group, Inc.Healthcare

$72.92−$22.01

-23.2%

NASDAQ · Mkt cap $3.1 B

TransMedics reported Q1 earnings and revenue that missed Wall Street expectations, with a 51% EPS miss and margin compression despite 21% revenue growth, triggering a sharp 23% sell-off as investors repriced the stock on disappointing profitability.

The headlines establish that TransMedics released Q1 2026 results on May 5-6 with a significant earnings per share miss of 51% versus consensus estimates, paired with a near-flat revenue miss of about 1%. While the company achieved 21% year-over-year revenue growth driven by its Organ Care System platform expansion, the earnings disappointment appears rooted in margin pressure the company disclosed during the earnings call. The discrepancy between strong top-line growth and weak bottom-line performance suggests rising costs, operational headwinds, or one-time charges that compressed profitability. For a medical device company valued on growth, an earnings miss of this magnitude combined with margin deterioration typically triggers a sharp repricing, particularly if forward guidance was tempered or cost pressures are expected to persist.

MNTN

MNTN Inc.Technology

$8.77−$2.59

-22.8%

RPGL

Republic Power Group Limited Class A Ordinary SharesTechnology

$1.33−$0.39

-22.7%

NASDAQ · Mkt cap $2.6 M

No news headlines were published in the last 48 hours for RPGL, so the 22.67% single-day drop cannot be attributed to a specific disclosed event. The decline likely stems from technical selling, sector weakness, liquidity dynamics, or undisclosed company developments.

The absence of recent news headlines makes it impossible to pinpoint a concrete catalyst for this sharp decline. RPGL is a micro-cap equity trading at $1.33, which typically means lower liquidity and higher sensitivity to technical factors, momentum shifts, or sector-wide pressure. The stock's rank as the 25th biggest loser suggests broader market or sector selling rather than a company-specific catalyst that would have appeared in the financial newswires. Possible explanations include a delayed earnings miss or guidance reduction not yet reflected in the headline feeds, adverse technical breakdown at key support levels, short liquidation following a rally, or negative commentary from an analyst. Without access to intraday trading patterns, institutional ownership data, or earnings announcements that may not yet have propagated through Yahoo Finance RSS, determining the specific cause remains speculative.

NICE

NICE Ltd.Technology

$96.85−$28.16

-22.5%

NASDAQ · Mkt cap $6.2 B

NICE beat Q1 earnings and revenue expectations but issued weaker-than-expected guidance for Q2 revenue, triggering a 22.5% selloff despite the strong quarterly beat.

NICE reported first-quarter 2026 results that exceeded Wall Street estimates on both revenue and earnings, with strong cloud growth and record new cloud ACV bookings. However, the company's forward guidance for second-quarter revenue came in softer than expected, which prompted an immediate selloff. The premarket drop of more than 9% mentioned in the headlines suggests the market was already digesting the guidance miss when the market opened, and the final 22.53% decline indicates the selling pressure intensified throughout the trading day. This is a classic "beat and raise" disappointment pattern where investors rewarded the strong quarterly execution but punished the lowered outlook, likely reflecting investor concern about growth deceleration or macro headwinds ahead. The valuation discussions and earnings comparisons in other headlines are secondary noise relative to this forward-looking miss.

HYPD

Hyperion DeFi, Inc.Healthcare

$3.64−$1.03

-22.1%

NASDAQ · Mkt cap $41 M

No news headlines were found in the last 48 hours, so the 22% decline cannot be directly attributed to a reported event; the move likely reflects sector volatility, technical selling, or an unreported catalyst in the DeFi space.

The absence of any news in the Yahoo Finance RSS feed over the past two days means we cannot pinpoint a specific catalyst such as earnings, guidance, regulatory action, or partnership announcements. Hyperion DeFi operates in the cryptocurrency and decentralized finance sector, which is known for high volatility and sensitivity to both macro sentiment shifts and protocol-level developments that may not always be immediately reflected in mainstream financial news feeds. A decline of this magnitude in a relatively small-cap DeFi token could stem from several categories: broad crypto market weakness, liquidations or leverage events in DeFi protocols, loss of key partnerships or developer talent, smart contract risks discovered post-launch, or simple technical selling after a preceding rally. Without headline evidence, we are constrained to structural inference about the sector's typical risk drivers rather than a specific identified cause.

QBTZ

Defiance Daily Target 2X Short QBTS ETF

$11.08−$3.06

-21.6%

NASDAQ

No news appeared in the last 48 hours, but QBTZ is a 2X short leveraged ETF, so a sharp 21.6% decline most likely reflects a strong rally in its underlying index or holdings, which would cause an inverse short ETF to drop sharply.

QBTZ is the Defiance Daily Target 2X Short QBTS ETF, meaning it is designed to move inversely and with 2X leverage to the QBTS index or basket. When the underlying assets surge, this short leveraged ETF falls proportionally. No news headlines were available in the last 48 hours to point to a specific market event, but the magnitude and direction of this move is entirely consistent with how leveraged inverse ETFs behave during sharp rallies in their underlying securities. The -21.64% drop suggests the underlying benchmark rose significantly, possibly due to sector rotation, a broad market rally, or a specific catalyst affecting the holdings that QBTS tracks. Without news context, we cannot identify the precise trigger, only infer that upward pressure on the underlying caused this inverse vehicle to lose value.

DZZ

DB Gold Double Short ETN

$1.85−$0.51

-21.6%

AMEX

No news headlines were found in the last 48 hours, but DZZ is a leveraged inverse gold ETN, so a sharp 21.6% decline most likely reflects a significant rise in gold prices overnight, which moves the fund in the opposite direction by design.

DZZ is a double-short leveraged ETN tracking inverse movements in gold, meaning it loses value when gold prices rise and gains when gold falls. The absence of company-specific news headlines does not indicate a lack of catalyst; rather, the catalyst is almost certainly a move in the underlying gold market itself. Gold prices are influenced by macroeconomic factors including interest rate expectations, US dollar strength, inflation data, geopolitical risk, and central bank policy signals. A 21.6% daily loss in a 2x inverse gold product is consistent with a 10-12% rally in gold futures or spot prices. Without access to gold price data or overnight market developments, the exact trigger cannot be pinpointed, but the structure of the fund makes it clear the move reflects gold strength rather than any DZZ-specific event or company action.

BNZI

Banzai International, Inc.Technology

$0.22−$0.06

-21.6%

NASDAQ · Mkt cap $5.6 M

Banzai announced a reverse stock split on May 6, which typically signals financial distress and often triggers immediate selling pressure regardless of the company's underlying operations.

The headline confirms Banzai announced a reverse stock split on the date of the 21.56% price drop. Reverse splits are generally perceived negatively by the market because they are commonly used by companies facing financial difficulty, delisting risk, or the need to restore share price above exchange minimums. While the full announcement text was truncated and does not provide the split ratio or stated rationale, the timing and the magnitude of the same-day decline strongly suggest the market reacted to the reverse split announcement itself rather than any operational news. The stock's position as the 30th biggest loser indicates broad selling pressure. Without detail on the split ratio or company guidance, we cannot determine whether the decline reflects pure mechanical delisting-risk concerns or additional adverse information disclosed in the full release.

CRTO

Criteo S.A.Communication Services

$15.86−$4.26

-21.2%

NASDAQ · Mkt cap $890 M

Criteo shares fell 21% following first-quarter 2026 earnings results reported on May 6, likely due to macro-related pressure mentioned in the earnings call and potential disappointment in guidance or forward outlook relative to investor expectations.

Criteo reported Q1 2026 results on the morning of May 6, with the earnings call highlights noting continued progress on its strategic shift toward commerce intelligence and AI decisioning but also explicitly mentioning macro-related pressure in parts of its performance business. The 21% single-day drop is a severe reaction typical of earnings misses or negative forward guidance. The company operates in the advertising technology and commerce intelligence space, where investor sentiment is sensitive to revenue growth rates, platform adoption, and macro conditions affecting advertiser spending. A concurrent headline about OpenAI launching a self-serve ChatGPT ad platform with lower minimums may also represent competitive pressure in the AI-driven advertising space, though this appears secondary to the earnings results themselves. Without access to the actual earnings numbers, guidance changes, or full call transcript, we cannot pinpoint whether the miss was revenue, profitability, user metrics, or guidance, but the timing and magnitude strongly suggest the earnings report itself triggered the decline.

OLOX

Olenox Industries Inc.Industrials

$0.47−$0.12

-21.0%

NASDAQ · Mkt cap $3.7 M

Olenox announced stockholder approval of a 1-for-10 reverse stock split on May 6, which typically signals financial distress and often triggers sharp sell-offs as investors anticipate dilution and delisting risk.

The company announced stockholder approval of a reverse stock split (1-for-10) on the same day as the 21% decline. Reverse splits are commonly used by companies trading at very low prices to avoid NASDAQ delisting thresholds, which require minimum bid prices. The announcement itself, combined with the stock's apparent distressed status (trading at $0.47), likely spooked investors who view reverse splits as a negative catalyst signaling financial trouble. A separate May 4 announcement about reorganization of subsidiary SG Echo LLC suggests ongoing strategic challenges. While the reverse split mechanically should not move price if applied uniformly, market psychology around such announcements among penny stocks is typically bearish. The timing of the split announcement coinciding with the largest single-day loss supports this as the primary driver, though we cannot rule out concurrent sector headwinds in energy or broader market factors not captured in the headlines.

GELS

Gelteq Limited Ordinary SharesHealthcare

$0.45−$0.11

-20.5%

NASDAQ · Mkt cap $6.0 M

No news headlines were found in the last 48 hours, so the 20.46% drop cannot be attributed to a specific disclosed event; the cause likely falls into technical selling, broader market pressure, or undisclosed company developments.

The absence of any news in the Yahoo Finance RSS feed over the past 48 hours means we cannot point to earnings, regulatory action, guidance changes, or announced corporate events as the driver of this sharp decline. For a microcap stock trading at $0.45, price movements of this magnitude are not uncommon and can be driven by several factors not captured in mainstream news feeds: heavy short-selling or covering, options expiration mechanics, penny-stock liquidation, sector-wide weakness affecting similar companies, insider selling, or loss of investor confidence tied to unannounced developments or social media discussion. Without access to trading volume, options activity, insider filings, or company-specific messaging, we cannot determine which of these categories is most likely responsible for today's move.

BMBL

Bumble Inc.Communication Services

$3.43−$0.86

-20.0%

NASDAQ · Mkt cap $427 M

Bumble shares crashed 20% after delivering a Q1 earnings beat but issuing weak forward guidance for Q2 revenue, signaling slowing user growth and monetization momentum despite a planned product overhaul.

Bumble reported Q1 2026 revenue of $212.4 million, beating analyst estimates by 0.24% and delivering a 33.54% earnings surprise. However, the market reaction was sharply negative, driven by two concrete headwinds disclosed on the earnings call. First, paying users are declining as the company executes a deliberate reset of its member base. Second, Q2 guidance came in weak at $209 million, representing a sequential decline and falling below expectations. The company is betting on a major product redesign later in 2026 to fix core issues with its swiping model and conversion from matches to dates, but investors appear unconvinced that a turnaround materialize soon enough. The year-over-year revenue decline of 14.1% further underscores the fundamental business deceleration, making the near-term guidance miss the dominant factor overshadowing the quarterly beat.

RGTZ

Daily Target 2X Short RGTZ ETF

$9.95−$2.43

-19.6%

NASDAQ

No news found in the last 48 hours to explain the 19.63% drop. Because RGTZ is a 2X short ETF, a sharp decline typically reflects a sharp rally in its underlying asset, which would mechanically trigger losses in an inverse leveraged product.

No headlines were available for the last 48 hours, so no specific news catalyst can be identified. However, RGTZ is a daily target 2X short ETF, meaning it is designed to deliver twice the inverse daily return of its reference index or underlying security. A 19.63% loss in this instrument is consistent with the underlying asset rallying roughly 10% or more in a single day. Leveraged inverse ETFs are also subject to daily rebalancing drift; extended rallies in the underlying erode their value structurally over time. Without access to what the underlying security is or today's broader market action, the most likely explanation is a significant rally in the reference asset, which would mechanically cause the short ETF to decline sharply, entirely independent of news.

EUDA

EUDA Health Holdings LimitedReal Estate

$13.17−$3.14

-19.3%

NASDAQ · Mkt cap $42 M

EUDA Health fell 19.25% with no news reported in the last 48 hours, suggesting the move was driven by internal corporate action, broad market weakness, technical factors, or information not yet reflected in major financial news feeds.

No headlines are available to explain EUDA's sharp 19.25% decline on May 6, 2026. The stock is ranked 36th among daily losers, indicating this was a material selloff. For a healthcare holding company, typical catalysts include earnings misses, FDA regulatory setbacks, clinical trial failures, pipeline updates, debt concerns, insider selling, or analyst downgrades. Without news in the RSS feed, the move could reflect a delayed disclosure of quarterly results, a private equity or institutional position unwind, gap-down reaction to after-hours or pre-market news not yet captured in headline services, or pressure from a broader healthcare sector rotation. It could also represent a technical breakdown or liquidation unrelated to company fundamentals.

BZAI

Blaize Holdings, Inc.Technology

$1.87−$0.44

-19.0%

NASDAQ · Mkt cap $81 M

Blaize announced a $35 million public stock offering on May 6, which triggered immediate shareholder dilution concerns and a 19% sell-off as existing holders faced equity dilution and downward pricing pressure.

The company announced the pricing of a $35 million underwritten public offering of common stock on May 6, 2026. This type of announcement typically causes immediate equity dilution concerns among existing shareholders, as new shares will be issued at the offering price, reducing ownership stakes and earnings per share. The timing of the announcement at or near market close on May 5 (announcement) followed by pricing on May 6 (execution) left little time for market adjustment before trading. Secondary offerings of this size are typically perceived negatively in the short term, especially for smaller-cap stocks where dilution has a material impact on per-share metrics. The 19% decline mirrors a common pattern for equity offerings at this scale, where the market immediately prices in dilution rather than waiting to see how the capital is deployed.

IONZ

Daily Target 2X Short IONQ ETF

$4.62−$1.08

-18.9%

NASDAQ

No news headlines are available for the last 48 hours, but IONZ is a 2X leveraged short ETF on IONQ, so its 18.95% decline likely reflects a sharp rise in the underlying IONQ stock price.

IONZ is a leveraged inverse ETF designed to deliver twice the daily negative return of IONQ. With no recent news provided, the decline cannot be attributed to any specific company announcement or market event affecting IONZ directly. However, the mechanical nature of this security means its price movements are primarily driven by IONQ's performance in the opposite direction. A roughly 9-10% intraday gain in IONQ would explain an 18-19% loss in IONZ, accounting for leveraging effects. Possible catalysts for IONQ strength could include positive quantum computing developments, analyst upgrades, institutional buying, short covering, or sector rotation into technology stocks, but these remain speculative without confirming headlines.

BFAM

Bright Horizons Family Solutions Inc.Consumer Cyclical

$66.36−$15.21

-18.6%

NYSE · Mkt cap $3.4 B

Bright Horizons reported Q1 earnings that beat estimates and reaffirmed full-year guidance, yet the stock fell 18.65% on May 6th, suggesting the market may have found the outlook insufficiently optimistic or concerns about execution despite positive near-term results.

The news headlines establish that BFAM delivered a positive quarter on May 5-6, with earnings beating by 3.37%, revenue meeting estimates with 7% year-over-year growth, and management describing results as a "positive start" to 2026. The company reaffirmed its full-year guidance and was recognized as a best place to work. Despite these objectively positive fundamentals, the stock experienced one of the day's largest declines. This disconnect suggests the market's reaction was driven by forward guidance concerns, margin expectations, or analyst commentary not captured in these headlines. Alternatively, the drop could reflect profit-taking after a strong run into earnings, sector weakness, or specific guidance commentary about growth rates or profitability that failed to excite investors despite beating on headline numbers. Without access to the full earnings call transcript details or analyst downgrades, the precise catalyst remains unclear.

AMDD

Direxion Daily AMD Bear 1X ETF

$3.99−$0.91

-18.6%

NASDAQ

No news headlines were reported in the last 48 hours, but AMDD is a 1X inverse ETF tracking AMD in reverse, so a decline reflects a likely rally in AMD stock itself on positive momentum or undisclosed positive developments.

No recent news headlines were found in the Yahoo Finance RSS feed for the last 48 hours. However, AMDD's structural function provides a clear explanation framework. AMDD is a Direxion Daily AMD Bear 1X ETF, meaning it is designed to move inversely to AMD stock on a daily basis. An 18.57% drop in AMDD therefore indicates that AMD stock likely rose significantly on May 5 or May 6, 2026. The catalyst for AMD's gain is not identified in the provided headlines, but common catalysts for semiconductor stocks include positive earnings surprises, analyst upgrades, broad market strength in the tech sector, new product announcements, or positive industry data. Without specific news attribution, the precise driver remains unknown, but the inverse relationship between this ETF and its underlying stock fully explains the directional move.

SOWG

Sow Good Inc.Consumer Defensive

$1.13−$0.26

-18.4%

NASDAQ · Mkt cap $68 M

Sow Good secured $20M in non-dilutive financing on May 5th to fund its graphite project acquisition and critical minerals pivot, yet the stock dropped 18.41% the next day, suggesting market skepticism about execution risk or valuation concerns despite the positive capital news.

The two news items from May 5th describe the same announcement: a $20 million non-convertible credit facility to support Sow Good's transition into critical minerals and battery anode development via a proposed Nachu Graphite acquisition. On the surface this is positive news—the company secured flexible, non-dilutive capital without convertible equity stakes. However, the 18.41% drop on May 6th despite this announcement indicates the market may be pricing in execution risk, skepticism about the graphite project's viability, concerns about the company's ability to service the debt, or disappointment that the capital raise was merely a credit facility rather than a strategic partnership or equity injection. Alternatively, the timing could reflect a delayed market reaction to other unannounced developments or technical selling in a micro-cap stock with thin liquidity.

MYGN

Myriad Genetics, Inc.Healthcare

$4.11−$0.92

-18.3%

NASDAQ · Mkt cap $292 M

Myriad Genetics fell 18.29% after reporting Q1 fiscal 2026 earnings that missed revenue expectations and posted a net loss, despite management reiterating full-year guidance.

The stock decline aligns directly with disappointing earnings results announced on May 5-6. While Myriad reported Q1 revenue of $200.4 million within its prior guidance range and showed 2% year-over-year growth, the company missed Wall Street's revenue estimates by 1.09% and reported a significant earnings miss of 56.52%, including a net loss for the quarter. The magnitude of the earnings shortfall, particularly the loss versus expected profit, appears to have triggered the sell-off despite management's assertion of "stable test volume" and progress in cancer care services. The company reiterated its full-year 2026 guidance, but that reassurance was insufficient to offset the disappointing quarterly results and the market's negative reaction to the loss itself. Investors likely interpreted the earnings miss as a sign of underlying business weakness or operational challenges in the genetic testing segment.

VMAR

Vision Marine Technologies Inc.Consumer Cyclical

$0.92−$0.20

-18.3%

NASDAQ · Mkt cap $4.6 M

Vision Marine announced a renewal and expansion of its floor plan credit facility to support inventory deployment, but this positive financing news appears to have been overshadowed by market skepticism or broader sector headwinds, resulting in an 18% drop.

The single headline provided is a financing announcement describing Vision Marine renewing and expanding its floor plan credit facility through the Nautical Ventures Platform. On surface, a facility expansion to support inventory deployment could be viewed as a positive operational development. However, the stock fell 18% on the day this news was released. The disconnect suggests either the market viewed the financing as dilutive, the expansion as insufficient relative to cash burn or operational challenges not mentioned in the headline, or that broader negative sentiment about the marine propulsion or recreational boating sector overwhelmed the news. Alternatively, investors may have reacted negatively to details in the full press release that are not captured in the headline snippet provided. Without access to the full announcement, analyst commentary, or competing sell-side research, a precise explanation is constrained.

SMRT

SmartRent, Inc.Technology

$1.17−$0.26

-18.2%

NYSE · Mkt cap $266 M

SmartRent reported Q1 revenue that beat estimates but posted a 6.4% year-over-year sales decline, triggering an 18% stock drop despite meeting earnings expectations, likely driven by investor disappointment over deteriorating top-line growth.

SmartRent released first-quarter 2026 results on May 6, 2026, with mixed outcomes. The company beat revenue expectations and posted a GAAP loss per share in line with forecasts, which normally would be neutral to slightly positive. However, the headline that dominated investor reaction was the 6.4% year-over-year revenue decline to $38.68 million. For a growth-focused technology company in the smart home space, a shrinking revenue base is a significant red flag regardless of operational metrics meeting consensus. The 18% single-day drop suggests the market was either expecting revenue growth or the magnitude of the YoY decline exceeded prior guidance and investor expectations. This represents a common scenario where forward guidance or implied growth assumptions matter far more than beating current-quarter estimates.

SDOT

Sadot Group Inc.Consumer Defensive

$0.41−$0.09

-17.8%

NASDAQ · Mkt cap $11 M

No news was reported in the last 48 hours, so the 17.78% drop on SDOT cannot be attributed to a specific announced catalyst. The move likely reflects either technical selling pressure, delayed market reaction to unreported news, or broader microcap volatility.

Despite a significant one-day decline ranking SDOT among the day's 45 biggest losers, no recent headlines were available to explain the move. For a microcap stock trading near $0.41, price swings of this magnitude can occur from multiple sources: thin liquidity and retail order imbalances, short-selling activity, delayed digestion of company announcements not yet picked up by major news feeds, earnings or guidance misses announced after market hours or on smaller platforms, or broader sector rotation out of penny stocks. Without access to company filings, earnings reports, insider transactions, or social media discussion on the snapshot date, determining the actual trigger remains speculative. The absence of news in the provided feed does not mean no event occurred—only that it was not captured in the Yahoo Finance RSS feed sampled.

COR

Cencora, Inc.Healthcare

$252.74−$53.16

-17.4%

NYSE · Mkt cap $63 B

Cencora fell 17.4% after Q2 earnings and revenue both missed analyst estimates, despite the company raising its full-year 2026 EPS guidance, suggesting the market prioritized the earnings miss and weak revenue growth over the raised outlook.

The earnings call occurred on May 6, 2026, with Cencora reporting Q2 fiscal 2026 results that underperformed expectations. Revenue came in at $78.4 billion, up 3.8% year-over-year but 2.98% below analyst consensus. Earnings per share beat by a modest margin (-1.04% surprise, meaning a slight miss). The healthcare distributor raised its full-year 2026 EPS outlook, which typically would support the stock, but this positive guidance adjustment appears to have been overwhelmed by the revenue shortfall. Headlines from pre-earnings coverage noted customer losses and pricing pressures as headwinds, which may have materialized in the quarter's results. The market's sharp 17% selloff suggests investors were positioned for a better earnings beat and rewarded the revenue miss more heavily than the guidance raise.

NEXR

Nexera Technologies LtdConsumer Cyclical

$1.84−$0.37

-16.7%

CVM

CEL-SCI CorporationHealthcare

$1.45−$0.29

-16.7%

JDST

Direxion Daily Junior Gold Miners Index Bear 2X ETF

$31.11−$6.20

-16.6%

AMEX

No news headlines were found in the last 48 hours, but JDST is a 2X inverse junior gold miners ETF, so a sharp -16.62% decline likely reflects a strong rally in junior gold mining stocks or broader precious metals strength on the snapshot date.

JDST is a leveraged inverse ETF that moves in the opposite direction of the Direxion Daily Junior Gold Miners Index, amplified by a factor of two. The absence of any news in the last 48 hours rules out company-specific catalysts or sector announcements as the direct cause. However, the magnitude of the decline is consistent with what this security is designed to do: when junior gold miners rally significantly, this inverse bear fund falls sharply. On May 6, 2026, spot gold prices likely rose substantially, or junior mining equities rallied on broader market sentiment, geopolitical risk appetite, or inflation expectations. Without headlines, the exact trigger remains unclear, but the structural nature of the ETF—shorting a leveraged junior mining index—explains why it moved against gold sentiment on this particular day.

NRGU

MicroSectors U.S. Big Oil 3 Leveraged ETN

$35.25−$7.02

-16.6%

AMEX

No news headlines were found in the last 48 hours, but NRGU is a 3x leveraged ETN tracking oil majors, so a sharp decline likely reflects a drop in crude oil prices or energy sector weakness that gets magnified by leverage.

The absence of company-specific news in the provided headlines makes it impossible to pinpoint a discrete catalyst. However, NRGU's structure is critical context: it is a leveraged ETN with 3x daily exposure to the Dow Jones U.S. Large-Cap Oil Index. A -16.61% single-day loss is consistent with a 5-6% decline in the underlying oil index, amplified by the 3x leverage factor. Oil prices or energy sector sentiment likely deteriorated in the past 48 hours due to macro factors—possible weakness in crude demand signals, a stronger dollar, geopolitical shifts affecting energy markets, or broader equity market selloff in the energy complex. Without confirmed headlines, the specific trigger remains unknown, but the magnitude and direction fit the leverage profile of this instrument.